Orbem
Munich
About Orbem
Orbem provides AI-powered imaging and analytics solutions that combine rapid magnetic resonance imaging with deep learning algorithms to reveal internal characteristics of biological materials that are not accessible through surface inspection. The company’s platform generates actionable intelligence by scanning and classifying objects such as eggs, seeds, and produce non-invasively, enabling decision-making in industrial workflows from agriculture to food production and biological research. Its technology supports applications like determining embryo attributes inside eggs and assessing the internal quality of agricultural products, translating complex biological data into structured insights for operational use. Orbem’s tools interface with automated systems to streamline classification and sorting tasks while providing data outputs that can inform process optimization, quality assessment, and transparency across value chains. The company collaborates with partners to integrate its imaging solutions into existing production environments and to expand into new use cases that benefit from internal biological visibility. Orbem’s approach emphasizes the practical deployment of AI-driven imaging to support technical teams in interpreting dense biological information and enhancing workflow outcomes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $106.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2026)
- Website: orbem.ai
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Information Technology, Sensor
Social Profiles
Canonical: https://fsome.com/organization/orbem-32649 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.